These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

95 related items for PubMed ID: 354904

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical examination of the synergistic effect of niflumic acid and tolperisone in genicular arthritis.
    Dömötör E.
    Ther Hung; 1979; 27(3):129-33. PubMed ID: 531773
    [No Abstract] [Full Text] [Related]

  • 25. Use of acute phase protein changes to assess the effects of a nonsteroidal antiinflammatory drug (niflumic acid) on the inflammation process induced by limited plastic surgery.
    Bienvenu J, Laurent P, Perrin LF, Colin B, Rebattu JP.
    Int J Clin Pharmacol Res; 1985; 5(4):269-72. PubMed ID: 2414236
    [Abstract] [Full Text] [Related]

  • 26. [Beta-morpholinoethyl ester of niflumic acid following surgery for vesico-ureteral reflux in children].
    Mazeman E, Biserte J, Willot I.
    LARC Med; 1982 Nov; 2(10):915-6. PubMed ID: 7167000
    [No Abstract] [Full Text] [Related]

  • 27. Niflumic acid in the management of rheumatoid and osteoarthritis.
    Tilve GH, Lengade JK, Bavadekar AV, Nair KG.
    J Postgrad Med; 1976 Jul; 22(3):124-9. PubMed ID: 1032826
    [No Abstract] [Full Text] [Related]

  • 28. [Preliminary study of the therapeutic action and tolerance of niflumic acid in pediatric otorhinolaryngology].
    Traissac L, Roche JC.
    Rev Laryngol Otol Rhinol (Bord); 1977 Jul; 98(5-6):317-21. PubMed ID: 897412
    [No Abstract] [Full Text] [Related]

  • 29. [Clinical study of the beta-morpholinoethylester of niflumic acid in children's dentistry].
    Benoit P, Michelet FX, Benoit JP.
    Rev Odontostomatol Midi Fr; 1975 Jul; (4):249-61. PubMed ID: 1236592
    [No Abstract] [Full Text] [Related]

  • 30. [Comparison of the effects of niflumic acid and aloxiprin in patients with progressive chronic rheumatoid arthritis in a double blind trial].
    Vojtisek O, Kanková D, Pavelka K, Hándlová D.
    Arzneimittelforschung; 1975 Aug; 25(8):1308-11. PubMed ID: 1101907
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. The effect of Donalgin on locomotor disease.
    Abrányi I, Papp I.
    Ther Hung; 1977 Aug; 25(1):20-3. PubMed ID: 854866
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Beta-morpholino-ethyl ester of niflumic acid in infectious syndromes in children].
    Fournier JL.
    Lille Med; 1977 Apr; 22(4 Suppl 1):286-9. PubMed ID: 875607
    [No Abstract] [Full Text] [Related]

  • 35. Examinations with Donalgin in locomotor diseases treated at the out-patient department.
    Kovács E.
    Ther Hung; 1977 Apr; 25(2):75-8. PubMed ID: 302503
    [No Abstract] [Full Text] [Related]

  • 36. Combined drug treatment of neurological inflammatory processes.
    Perényi G.
    Ther Hung; 1981 Apr; 29(4):186-90. PubMed ID: 7188145
    [No Abstract] [Full Text] [Related]

  • 37. [Niflumic acid combined with gastroprotective agents in rheumatic pathology].
    Serni U, Frosecchi M.
    Reumatismo; 1974 Apr; 26(2):109-28. PubMed ID: 4282512
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.